Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (4243)	2/13/2003 12:22:55 PM
From: Mike M	Respond to of 5582

MTXX earnings news: biz.yahoo.com Matrixx Initiatives, Inc. Schedules Q4 and 2002 Annual Earnings Teleconference for Friday, February 21, 2003 Thursday February 13, 11:47 am ET Zicam Manufacturer to Discuss Record Sales, Upgraded Earnings Report PHOENIX, Feb. 13 /PRNewswire-FirstCall/ -- Matrixx Initiatives, Inc., (Nasdaq: MTXX - News) announced that it will hold a conference call to discuss its fourth quarter and year-end 2002 operating results on Friday, February 21, 2003 at 10:30 a.m. EST. Carl J. Johnson, president and chief executive officer, and William J. Hemelt, executive vice president and chief financial officer, will recap the fourth quarter results, discuss the year in review, and provide an overview of the corporate growth strategy for 2003. Matrixx previously announced that its year-over-year revenue growth will surpass previous guidance of 25-30 percent, based on initial, unaudited fourth quarter results. The upgraded projected growth in sales during 2002 is expected to exceed 40 percent over 2001 sales and reflects a doubling of fourth quarter sales above the comparable period in 2001. The company also said that it expects to report a slight profit from operations in the fourth quarter of 2002 and reiterated previous guidance that it would be profitable and cash flow positive for the full year. The guidance upgrade was followed by the recent announcement that the company's Zicam Cold Remedy nasal gel, Zicam Allergy Relief, Zicam Cold Remedy Swabs, Zicam Kids Size Cold Remedy Swabs, and Zicam Extreme Congestion Relief products represented five of the top 10 items (SKUs) on a dollar sales per point of distribution basis among cold and allergy internal nasal products sold in drug stores during the last 12 weeks of 2002. To access the teleconference, please call 877-692-2588 in the United States or 973-582-2745 for international callers. To listen to the teleconference via the Internet, go to www.matrixxinc.com and click on the teleconference icon. To listen to an audio replay of the conference call, dial 877-519-4471 and enter code 3747419. The audio replay will be available beginning at 1:00 p.m. EST on February 21, 2003 until 12:00 a.m. on February 28, 2003.